logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Central Nervous System Diseases

    FiltersReset Filters
    4 results

    • gadavist

      (gadobutrol)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Gadavist is indicated for MRI of the CNS, breast, magnetic resonance angiography (MRA), and cardiac MRI to detect abnormalities, assess malignant breast disease, evaluate artery disease, and assess myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease.

    • gadobutrol

      (Gadobutrol)
      Fresenius Kabi USA, LLC
      Usage: Gadobutrol injection is indicated for use in MRI of the CNS to visualize blood-brain barrier disruptions, in MRI of the breast for malignant disease assessment, in MRA for vascular disease evaluation, and in cardiac MRI to assess myocardial perfusion and coronary artery disease in adults.

    • multihance

      (gadobenate dimeglumine)
      BRACCO DIAGNOSTICS INC
      Usage: MultiHance is indicated for intravenous use in MRI of the central nervous system to visualize lesions with abnormal blood-brain barrier or vascularity. It is also used in magnetic resonance angiography to evaluate adults for renal or aorto-ilio-femoral occlusive vascular disease.

    • multihance

      (gadobenate dimeglumine)
      BRACCO DIAGNOSTICS INC
      Usage: MultiHance is indicated for intravenous use in magnetic resonance imaging (MRI) of the central nervous system to visualize lesions with abnormal blood-brain barrier or vascularity in adults and pediatrics. It is also used in magnetic resonance angiography (MRA) for assessing renal and aorto-ilio-femoral vascular diseases.